Abstract

The purpose of study was to analyze relationships between polymorphism of genes TNFα (-308GA) and IL6 (-174CG) and functional condition of kidneys in patients with various phenotype of obesity. The sampling included 170 individuals aged from 25 to 55 years (90 patients with obesity, metabolic disorders and arterial hypertension - group of "complicated obesity", 50 individuals with obesity without metabolic complications - group of "metabolically healthy obesity" and 30 individuals with arterial hypertension without obesity). The analysis was applied to clinical biochemical indices, levels of TNFα, IL-6 in blood serum and urine, microalbuminuria, collagen IV in urine, polymorphism of genes TNFα (-308GA) and IL6 (-174CG). The analysis established that the group I of patients (with complicated obesity) was characterized by higher levels of TNFα and IL6 in blood and urine, microalbuminuria and collagen IV. In this group, in contrast with control group, prevailed minor allele AA of gene TNFα (χ2 = 14,70; р = 0,04) and GG of gene IL6 (χ2 = 1,90; р = 0,04). The carriage of homozygote of AA of gene TNFα in the group was more often combined with moderate decreasing of velocity of glomerular filtration (χ2 = 2,15; р = 0,04), homozygote of GG of gene IL-6 in group with level of microalbuminuria more than 30 mg per day (χ2 = 2,8; р = 0,04). The association was established between polymorphism of gene TNFα (-308GА) and level of systolic arterial pressure (р = 0,04), diastolic arterial pressure (р = 0,02), IL6 of blood (р = 0,04), TNFα (р = 0,027). The carriage of minor alleles - AA of gene TNFα and GG of gene IL6 is associated with development of arterial pressure and metabolically complicated obesity. The polymorphism of genes TNFα (-308GА) and IL6 (-174СG) can selectively effect spontaneous production of anti-inflammatory cytokines and is associated with disorder of kidney function. The association of increased level of TNFα and IL6 with decreasing of kidneys function testifies their input into development and progression of chronic kidneys disease.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.